BioSpace News Archive

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today released its third annual cybersecurity report to update stakeholders about the company’s ongoing efforts to advance cybersecurity maturity, protect against cyberattacks and empower customers with information about cyber risks and vulnerabilities.

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 second quarter on Wednesday, February 1, 2023, after the market closes.

Intrarosa ® is now available in Canada and offers a new treatment option for Canadian physicians and their patients with postmenopausal vulvovaginal atrophy (VVA).

Juvena Therapeutics , Inc. announced today the hiring of four senior leaders with significant industry experience in both small and large pharmaceutical and biotech companies.

Precision Neuroscience Corporation, the only brain–computer interface company developing implants that are designed to be high-resolution, minimally invasive, and reversible, announced a $41 million Series B funding round led by Forepont Capital Partners.

Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2022.

Pliant Therapeutics, Inc. today announced Ms. Lily Cheung as its Chief Human Resources Officer.

Vera Therapeutics, Inc. today announced that it will host a virtual key opinion leader (KOL) event featuring Jonathan Barratt, PhD, FRCP, from the University of Leicester, who, together with Vera Therapeutics management, will provide an update on atacicept’s ORIGIN Phase 2b data in IgA nephropathy (IgAN).

Children’s Hospital Los Angeles (CHLA) has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with Down syndrome.

Forge Biologics today the addition of three key leadership hires to further the Company’s growth as a leading manufacturer of genetic medicines.